CN1115412C - 前尿激酶突变体 - Google Patents
前尿激酶突变体 Download PDFInfo
- Publication number
- CN1115412C CN1115412C CN94193246A CN94193246A CN1115412C CN 1115412 C CN1115412 C CN 1115412C CN 94193246 A CN94193246 A CN 94193246A CN 94193246 A CN94193246 A CN 94193246A CN 1115412 C CN1115412 C CN 1115412C
- Authority
- CN
- China
- Prior art keywords
- pro
- urokinase
- lys
- mutant
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (11)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/087,163 US5472692A (en) | 1993-07-02 | 1993-07-02 | Pro-urokinase mutants |
US08/087,163 | 1993-07-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1130402A CN1130402A (zh) | 1996-09-04 |
CN1115412C true CN1115412C (zh) | 2003-07-23 |
Family
ID=22203481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94193246A Expired - Lifetime CN1115412C (zh) | 1993-07-02 | 1994-06-28 | 前尿激酶突变体 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5472692A (zh) |
EP (2) | EP0714435B1 (zh) |
JP (2) | JPH08511953A (zh) |
CN (1) | CN1115412C (zh) |
AT (1) | ATE239084T1 (zh) |
CA (1) | CA2165977A1 (zh) |
DE (1) | DE69432592T2 (zh) |
ES (1) | ES2197165T3 (zh) |
NZ (1) | NZ269061A (zh) |
PT (1) | PT714435E (zh) |
WO (1) | WO1995001427A1 (zh) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7544500B2 (en) * | 1999-11-13 | 2009-06-09 | Talecris Biotherapeutics, Inc. | Process for the production of a reversibly inactive acidified plasmin composition |
US6964764B2 (en) * | 1999-11-13 | 2005-11-15 | Talecris Biotherapeutics, Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US6969515B2 (en) | 1999-11-13 | 2005-11-29 | Talecris Biotherapeutics, Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US6355243B1 (en) * | 1999-11-13 | 2002-03-12 | Bayer Corporation | Method of thrombolysis by local delivery of active plasmin |
CZ303658B6 (cs) * | 2001-02-01 | 2013-02-06 | F. Hoffmann-La Roche Ag | Zpusob rekombinantní produkce trypsinu |
CN1311076C (zh) * | 2003-04-16 | 2007-04-18 | 普罗特奥姆技术公司 | 生产重组尿激酶的方法 |
US7070958B2 (en) * | 2003-04-18 | 2006-07-04 | Thrombolytic Science, Inc. | Methods of making pro-urokinase mutants |
CA2426115A1 (en) * | 2003-04-18 | 2004-10-18 | Victor Gurewich | Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
GB2446550B (en) * | 2005-11-28 | 2010-12-08 | Proteomtech Inc | Methods for production of recombinant alpha1-antitrypsin |
CN101024827B (zh) * | 2006-02-22 | 2012-05-30 | 中国科学院福建物质结构研究所 | 尿激酶催化结构域突变体的表达、纯化以及结晶 |
CN100441683C (zh) * | 2006-03-24 | 2008-12-10 | 中国人民解放军军事医学科学院生物工程研究所 | 低分子量尿激酶突变体及其表达载体 |
US20070298024A1 (en) * | 2006-06-22 | 2007-12-27 | Thrombolytic Science, Inc. | C-1 inactivator inhibits two-chain urokinase mutant and limits hemostatic bleeding during thrombolysis |
US7837992B2 (en) * | 2006-06-22 | 2010-11-23 | Beth Israel Deaconess Medical Center | C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis |
KR101476458B1 (ko) | 2006-07-05 | 2015-01-05 | 카탈리스트 바이오사이언시즈, 인코포레이티드 | 프로테아제 스크리닝 방법 및 이에 의해 확인된 프로테아제 |
EP1936531A1 (en) * | 2006-12-20 | 2008-06-25 | Thomson Licensing | Methods and device for secure software installation |
US8507646B2 (en) * | 2007-02-23 | 2013-08-13 | Landing Biotech, Inc. | Treating atherosclerosis |
KR20110017903A (ko) * | 2008-06-04 | 2011-02-22 | 테일크리스 바이오쎄러퓨틱스 아이엔씨. | 플라스민의 제조를 위한 조성물, 방법 및 키트 |
US20100143325A1 (en) * | 2008-12-09 | 2010-06-10 | Vascular Laboratory, Inc. | Composition And Methods Involving Thrombolytic Agents |
PL2403865T3 (pl) | 2009-03-03 | 2016-01-29 | Grifols Therapeutics Inc | Sposoby wytwarzania plazminogenu |
US20160146834A1 (en) | 2013-07-12 | 2016-05-26 | Emory University | Diagnostic assay to predict cardiovascular risk |
RU2553533C2 (ru) * | 2013-10-23 | 2015-06-20 | Общество с ограниченной ответственностью "Международный биотехнологический центр "Генериум" ("МБЦ "Генериум") | Способ выделения и очистки рекомбинантной человеческой проурокиназы м5 |
DK3215221T3 (da) | 2014-11-03 | 2020-05-11 | Thrombolytic Science Llc | Fremgangsmåder og sammensætninger til sikker og effektiv trombolyse |
US11154596B2 (en) | 2017-06-16 | 2021-10-26 | Thrombolytic Science, Llc | Methods for thrombolysis |
MX2020010091A (es) | 2018-03-27 | 2021-01-15 | Umc Utrecht Holding Bv | Trombolisis direccionada para tratamiento de trombosis microvascular. |
MX2021007843A (es) * | 2018-12-28 | 2021-08-11 | Vertex Pharma | Polipeptidos de activador de plasminogeno, tipo urocinasa, modificados y metodos de uso. |
US11613744B2 (en) | 2018-12-28 | 2023-03-28 | Vertex Pharmaceuticals Incorporated | Modified urokinase-type plasminogen activator polypeptides and methods of use |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5108901A (en) * | 1988-09-02 | 1992-04-28 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989007641A1 (en) * | 1988-02-10 | 1989-08-24 | Genzyme Corporation | Enhancement of the therapeutic properties of glycoprotein |
EP0387380A1 (en) * | 1989-03-17 | 1990-09-19 | BEHRINGWERKE Aktiengesellschaft | Mutants of urinary plasminogen activator, their production and use |
-
1993
- 1993-07-02 US US08/087,163 patent/US5472692A/en not_active Expired - Fee Related
-
1994
- 1994-06-28 EP EP94922037A patent/EP0714435B1/en not_active Expired - Lifetime
- 1994-06-28 JP JP7503598A patent/JPH08511953A/ja active Pending
- 1994-06-28 CA CA002165977A patent/CA2165977A1/en not_active Abandoned
- 1994-06-28 AT AT94922037T patent/ATE239084T1/de not_active IP Right Cessation
- 1994-06-28 ES ES94922037T patent/ES2197165T3/es not_active Expired - Lifetime
- 1994-06-28 NZ NZ269061A patent/NZ269061A/en unknown
- 1994-06-28 CN CN94193246A patent/CN1115412C/zh not_active Expired - Lifetime
- 1994-06-28 DE DE69432592T patent/DE69432592T2/de not_active Expired - Fee Related
- 1994-06-28 EP EP03009709A patent/EP1361276A1/en not_active Withdrawn
- 1994-06-28 PT PT94922037T patent/PT714435E/pt unknown
- 1994-06-28 WO PCT/US1994/007278 patent/WO1995001427A1/en active IP Right Grant
-
2004
- 2004-07-07 JP JP2004200871A patent/JP2004337172A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5108901A (en) * | 1988-09-02 | 1992-04-28 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
Also Published As
Publication number | Publication date |
---|---|
US5472692A (en) | 1995-12-05 |
DE69432592T2 (de) | 2004-04-01 |
DE69432592D1 (de) | 2003-06-05 |
ES2197165T3 (es) | 2004-01-01 |
PT714435E (pt) | 2003-08-29 |
JPH08511953A (ja) | 1996-12-17 |
EP0714435B1 (en) | 2003-05-02 |
NZ269061A (en) | 1997-03-24 |
ATE239084T1 (de) | 2003-05-15 |
WO1995001427A1 (en) | 1995-01-12 |
EP1361276A1 (en) | 2003-11-12 |
EP0714435A1 (en) | 1996-06-05 |
CA2165977A1 (en) | 1995-01-12 |
CN1130402A (zh) | 1996-09-04 |
JP2004337172A (ja) | 2004-12-02 |
EP0714435A4 (en) | 1997-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1115412C (zh) | 前尿激酶突变体 | |
Renatus et al. | Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA | |
Jalving et al. | Characterization of the kexin-like maturase of Aspergillus niger | |
JPS62104577A (ja) | ポリクリングルプラスミノ−ゲン活性化因子 | |
CN1768138A (zh) | 在微生物中生产重组蛋白质的方法 | |
BG60253B2 (bg) | Човешки тъканен плазминогенен активатор | |
CN1150824A (zh) | 来自米曲霉的areA基因和其中areA基因已被修饰的真菌 | |
EP0200451A1 (en) | Protease resistant urokinase composition, its production and use | |
CN1839203A (zh) | 因子VII或VIIa的GLA结构域变体 | |
CN1054798A (zh) | 表达酶原形式的人蛋白c的载体和化合物 | |
Foster et al. | Endoproteolytic processing of the human protein C precursor by the yeast Kex2 endopeptidase coexpressed in mammalian cells | |
CN1197969C (zh) | α-淀粉酶突变体 | |
CN1055560A (zh) | 表达人蛋白c糖基化突变体的载体和化合物 | |
CN100347297C (zh) | 利用基因工程技术制备人凝血酶的方法 | |
Mei et al. | Engineering subtilisin YaB: restriction of substrate specificity by the substitution of Gly124 and Gly151 with Ala. | |
Ning et al. | Cloning, expression and characterization of a novel fibrinolytic serine metalloproteinase from bacillus velezensis SW5 | |
KOO et al. | Identification of active-site residues in Bradyrhizobium japonicum malonamidase E2 | |
Guerrero‐Olazarán et al. | Recombinant shrimp (Litopenaeus vannamei) trypsinogen production in Pichia pastoris | |
Baek et al. | Characteristics of a new enantioselective thermostable dipeptidase from Brevibacillus borstelensis BCS-1 and its application to synthesis of a D-amino-acid-containing dipeptide | |
US4997766A (en) | Poly-kringle plasminogen activator | |
US7867747B2 (en) | Fibrinolytic metalloprotease and composition comprising the same | |
CN1342200A (zh) | 晶体TNF-α-转换酶及其应用 | |
CN1226926A (zh) | 可凝血酶活化的血纤溶酶原激活物 | |
CN1244894A (zh) | 组织型纤溶酶原活化剂(t-PA)变体:组合物及使用方法 | |
US5045315A (en) | Process for treating thrombosis by administering poly-kringle plasminogen activator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LIU JIANNING Free format text: FORMER OWNER: NEW ENGLAND DEACONESS HOSPITAL CORP. Effective date: 20030919 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20030919 Address after: Suzhou City, Jiangsu Province, 215001 yuan 63 Tongfang Pro Dayton Road Patentee after: Liu Jianning Address before: Massachusetts USA Patentee before: New England Deaconess Hospital Corp. |
|
ASS | Succession or assignment of patent right |
Owner name: SUZHOU LANDING BIOPHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LIU JIANNING Effective date: 20111109 Owner name: LIU JIANNING Free format text: FORMER OWNER: NEW ENGLAND DEACONESS HOSPITAL CORP. Effective date: 20111109 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; TO: 215001 SUZHOU, JIANGSU PROVINCE Free format text: CORRECT: ADDRESS; FROM: 215001 SUZHOU, JIANGSU PROVINCE TO: 215028 SUZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20111109 Address after: 215028 No. 118 Longtan Road, Suzhou Industrial Park, Jiangsu Patentee after: Suzhou Landing Biopharmaceutical Co.,Ltd. Address before: Suzhou City, Jiangsu province 215001 Pro Dayton road Tongfang Road No. 63 Patentee before: Liu Jianning Effective date of registration: 20111109 Address after: Suzhou City, Jiangsu province 215001 Pro Dayton road Tongfang Road No. 63 Patentee after: Liu Jianning Address before: Massachusetts USA Patentee before: New England Deaconess Hospital Corp. |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20140628 Granted publication date: 20030723 |